Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Procter & Gamble

This article was originally published in The Tan Sheet

Executive Summary

Procter & Gamble: Bruce Byrnes, 47, formerly head of P&G's North American paper products business, appointed to president of health care products-North America with responsibility for prescription and OTC pharmaceuticals. Byrnes succeeds Thomas Moore, 45, who has left P&G "to pursue a new career opportunity." Moore also is leaving his position as vice chairman of NDMA's board of directors. P&G indicated that it has not yet named a successor to Moore to serve as the company's official representative with the association...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS084898

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel